Publications by authors named "Tycho Baumann"

51Publications

Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact.

Haematologica 2020 Nov 5;Online ahead of print. Epub 2020 Nov 5.

Department of Hematology, Hospital Clínic, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid.

View Article and Find Full Text PDF
November 2020

The BALL prognostic score identifies relapsed/refractory CLL patients who benefit the most from single-agent ibrutinib therapy.

Leuk Res 2020 08 10;95:106401. Epub 2020 Jun 10.

Department of Hematology, Institute of Hematology and Oncology, Hospital Clínic, University of Barcelona, Barcelona, Spain.

View Article and Find Full Text PDF
August 2020

High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era.

Leuk Res 2020 07 19;94:106371. Epub 2020 May 19.

Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Universitat de Barcelona, Barcelona, Spain. Electronic address:

View Article and Find Full Text PDF
July 2020

CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report.

Leukemia 2020 07 19;34(7):1954-1956. Epub 2020 May 19.

Department of Hematology, Hospital Clinic University of Barcelona, Barcelona, Spain.

View Article and Find Full Text PDF
July 2020

Ibrutinib as initial therapy in chronic lymphocytic leukemia: A systematic review and meta-analysis.

Eur J Haematol 2020 May 22;104(5):512-515. Epub 2020 Feb 22.

Department of Hematology, Hospital Clinic, University of Barcelona, Barcelona, Spain.

View Article and Find Full Text PDF
May 2020

Analysis of criteria for treatment initiation in patients with progressive chronic lymphocytic leukemia.

Blood Cancer J 2018 01 16;8(1):10. Epub 2018 Jan 16.

Department of Hematology, Institute of Hematology and Oncology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

View Article and Find Full Text PDF
January 2018

Massive erythrophagocytosis by peripheral monocytes and neutrophils in parvovirus-B19 autoimmune hemolytic anemia.

Ann Hematol 2017 May 21;96(5):881-882. Epub 2017 Feb 21.

Biomedical Diagnostic Center, Hospital Clínic of Barcelona, Villarroel, 170, 08036, Barcelona, Spain.

View Article and Find Full Text PDF
May 2017

CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status.

Br J Haematol 2016 Jan 12;172(1):48-55. Epub 2015 Nov 12.

Department of Haematology, Institute of Haematology and Oncology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

View Article and Find Full Text PDF
January 2016

Mutations in CHD2 cause defective association with active chromatin in chronic lymphocytic leukemia.

Blood 2015 Jul 1;126(2):195-202. Epub 2015 Jun 1.

Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo, Oviedo, Spain;

View Article and Find Full Text PDF
July 2015

New treatment options for chronic lymphocytic leukemia.

Expert Opin Pharmacother 2014 Apr 22;15(6):823-32. Epub 2014 Feb 22.

University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Institute of Hematology and Oncology, Hospital Clínic, Department of Hematology , Villaroel 170, 08036 Barcelona , Spain +34 93 227 54 75 ; +34 93 227 98 11 ;

View Article and Find Full Text PDF
April 2014

Rituximab-based chemoimmunotherapy prolongs survival of patients with chronic lymphocytic leukemia independently of the time of administration.

Clin Lymphoma Myeloma Leuk 2014 Feb 12;14(1):73-9. Epub 2013 Oct 12.

Institute of Hematology and Oncology, Department of Hematology, Hospital Clinic, IDIBAPS, Barcelona, Spain. Electronic address:

View Article and Find Full Text PDF
February 2014

MicroRNA expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemia.

Leuk Lymphoma 2013 Sep 29;54(9):2016-22. Epub 2013 Jan 29.

Institute of Hematology and Oncology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.

View Article and Find Full Text PDF
September 2013

Retreatment with purine analogs in patients with chronic lymphocytic leukemia.

Leuk Res 2012 Dec 28;36(12):1521-5. Epub 2012 Aug 28.

Institute of Hematology and Oncology, Department of Hematology, Hospital Clinic, Barcelona, Spain.

View Article and Find Full Text PDF
December 2012

Chronic lymphocytic leukemia therapy: beyond chemoimmunotherapy.

Curr Pharm Des 2012 ;18(23):3356-62

Institute of Hematology and Oncology, Department of Hematology, Hospital Clinic, Institut d’Investigacions Biomèdiques August Pi iSunyer, University of Barcelona, Spain.

View Article and Find Full Text PDF
December 2012

Combined analysis of levels of serum B-cell activating factor and a proliferation-inducing ligand as predictor of disease progression in patients with chronic lymphocytic leukemia.

Leuk Lymphoma 2011 Nov 27;52(11):2064-8. Epub 2011 Jun 27.

Institute of Hematology and Oncology, Department of Hematology, University of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

View Article and Find Full Text PDF
November 2011

Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance.

Blood 2010 Dec 24;116(23):4771-6. Epub 2010 Aug 24.

Institute of Hematology and Oncology, Hematology Department, Hospital Clínic University of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

View Article and Find Full Text PDF
December 2010